BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 4268202)

  • 21. Subarachnoid hemorrhage.
    Maddox M
    Am J Nurs; 1974 Dec; 74(12):2199-201. PubMed ID: 4497432
    [No Abstract]   [Full Text] [Related]  

  • 22. Arteriopathic complications during treatment of subarachnoid hemorrhage with epsilon-aminocaproic acid.
    Sonntag VK; Stein BM
    J Neurosurg; 1974 Apr; 40(4):480-5. PubMed ID: 4814379
    [No Abstract]   [Full Text] [Related]  

  • 23. Antifibrinolytics in the treatment of subarachnoid hemorrhage due to rupture of arterial aneurysm.
    Schisano G
    J Neurosurg Sci; 1974; 18(1):39-46. PubMed ID: 4549070
    [No Abstract]   [Full Text] [Related]  

  • 24. A method for monitoring antifibrinolytic therapy in patients with ruptured intracranial aneurysms.
    Burchiel KJ; Schmer G
    J Neurosurg; 1981 Jan; 54(1):12-5. PubMed ID: 7463112
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Letter: Epsilon-aminocaproic acid and subarachnoid haemorrhage.?211.
    Shaw MD; Miller JD
    Lancet; 1974 Oct; 2(7884):847-8. PubMed ID: 4138300
    [No Abstract]   [Full Text] [Related]  

  • 26. [Coagulation physiological controls in subarachnoid hemorrhages and their therapeutic implications].
    Hindersin P; Endler S; Heidrich R
    Psychiatr Neurol Med Psychol (Leipz); 1982 Apr; 34(4):236-41. PubMed ID: 7100333
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Monitoring of antifibrinolytic therapy following subarachnoid hemorrhage. The importance of CSF fibrin/fibrinogen degradation products.
    Sawaya R; Sonnino V; McLaurin RL; Perrotta G
    J Neurosurg; 1983 May; 58(5):699-707. PubMed ID: 6834119
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Earlier operation and antifibrinolytic therapy in the management of aneurysmal subarachnoid haemorrhage. Review of recent experience in Tasmania.
    Corkill G
    Med J Aust; 1974 Mar; 1(13):468-70. PubMed ID: 4830928
    [No Abstract]   [Full Text] [Related]  

  • 29. Alterations of coagulation and fibrinolysis in cerebrospinal fluid in subarachnoid haemorrhage.
    Hindersin P; Endler S
    J Neurosurg Sci; 1986; 30(4):183-6. PubMed ID: 3559736
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HAEMORRHAGE AND FIBRINOLYSIS.
    FLUTE PT
    Proc R Soc Med; 1964 Jul; 57(7):603-6. PubMed ID: 14178952
    [No Abstract]   [Full Text] [Related]  

  • 31. Antifibrinolytics in aneurysmal subarachnoid haemorrhage. A retrospective comparison of two different forms of antifibrinolytic therapy.
    Spallone A
    Acta Neurochir (Wien); 1982; 63(1-4):245-50. PubMed ID: 6179402
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Antifibrinolytic therapy of gynecologic hemorrhages (literature survey)].
    Skipetrov VP
    Akush Ginekol (Mosk); 1974 Oct; (10):1-6. PubMed ID: 4280255
    [No Abstract]   [Full Text] [Related]  

  • 33. [Fibrinolytic activity of cerebrospinal fluid in subarachnoid hemorrhage (author's transl)].
    Imanaga H; Osugi T; Kagawa M; Kita-Mura K
    No Shinkei Geka; 1977 Jan; 5(1):51-8. PubMed ID: 557178
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preoperative management of patients with ruptured intracranial aneurysms.
    Ransohoff J; Goodgold A; Benjamin MV
    J Neurosurg; 1972 May; 36(5):525-30. PubMed ID: 5026538
    [No Abstract]   [Full Text] [Related]  

  • 35. Letter: Epsilon-aminocaproic acid and subarachnoid haemorrhage.
    Corkill G
    Lancet; 1974 Nov; 2(7892):1319. PubMed ID: 4139550
    [No Abstract]   [Full Text] [Related]  

  • 36. [Coagulation-fibrinolysis abnormalities in acute stage of subarachnoid hemorrhage (Part 1)--With special reference to the relation between cerebral vasospasm and fibrinopeptides A and B beta].
    Touho H; Hino A; Suzuki K; Kubo T; Hirakawa K
    No To Shinkei; 1984 Oct; 36(10):1009-14. PubMed ID: 6518124
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Substances inhibiting fibrinolysis].
    Lakin KM; Rachitskaia NG; Gavrilov AP
    Kardiologiia; 1972 Apr; 12(4):139-53. PubMed ID: 4558033
    [No Abstract]   [Full Text] [Related]  

  • 38. Antifibrinolytic therapy in the treatment of subarachnoid haemorrhage caused by arterial aneurysms.
    Profeta G; Castellano F; Guarnieri L; Cigliano A; Amborsio A
    J Neurosurg Sci; 1975; 19(1-2):77-8. PubMed ID: 1221103
    [No Abstract]   [Full Text] [Related]  

  • 39. Experimental epsilon-aminocaproic acid (EACA) administration in the presence of subarachnoid blood.
    Ewald T; Mahaley S; Goodrich J; Wilkinson R; Silver D
    J Neurosurg; 1971 Dec; 35(6):657-63. PubMed ID: 5171110
    [No Abstract]   [Full Text] [Related]  

  • 40. [Antifibrinolytic treatment after subarachnoid hemorrhage].
    Marchel A
    Neurol Neurochir Pol; 1992; 26(4):502-10. PubMed ID: 1484577
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.